{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:48:24Z","timestamp":1793915304884,"version":"4.8.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,4,15]],"date-time":"2011-04-15T00:00:00Z","timestamp":1302825600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s00259-011-1812-2","type":"journal-article","created":{"date-parts":[[2011,4,14]],"date-time":"2011-04-14T05:05:12Z","timestamp":1302757512000},"page":"1393-1406","source":"Crossref","is-referenced-by-count":202,"title":["EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds"],"prefix":"10.1007","volume":"38","author":[{"name":"the Therapy, Oncology and Dosimetry Committees","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Giammarile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Bodei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Chiesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Flux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Forrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Kraeber-Bodere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boudewijn","family":"Brans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bieke","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Konijnenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Borson-Chazot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Tennvall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Luster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,4,15]]},"reference":[{"key":"1812_CR1","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E","volume":"56","author":"K Okuda","year":"1985","unstructured":"Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985;56:918\u201328.","journal-title":"Cancer"},{"key":"1812_CR2","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(98)09148-X","volume":"353","author":"DF Schafer","year":"1999","unstructured":"Schafer DF, Sorrell MF. Hepatocellular carcinoma. Lancet 1999;353:1253\u20137.","journal-title":"Lancet"},{"key":"1812_CR3","unstructured":"Leong As-Y, Liew CT, Lau JWY, Johnson PJ, editors. Hepatocellular carcinoma: contemporary diagnosis, investigation and management. London: Arnold; 1999."},{"key":"1812_CR4","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/bjs.1800780804","volume":"78","author":"JR Novell","year":"1991","unstructured":"Novell JR, Hilson A, Hobbs KE. Therapeutic aspects of radio-isotopes in hepatobiliary malignancy. Br J Surg 1991;78:901\u20136.","journal-title":"Br J Surg"},{"key":"1812_CR5","first-page":"1782","volume":"35","author":"JL Raoul","year":"1994","unstructured":"Raoul JL, Guyader D, Bretagne JF, Duvauferrier R, Bourguet P, Bekhechi D, et al. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support. J Nucl Med 1994;35:1782\u20137.","journal-title":"J Nucl Med"},{"key":"1812_CR6","first-page":"1156","volume":"26","author":"JL Raoul","year":"1997","unstructured":"Raoul JL, Guyader D, Bretagne JF, Heautot JF, Duvauferrier R, Bourguet P, et al. Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma. Hepatology 1997;26:1156\u201361.","journal-title":"Hepatology"},{"key":"1812_CR7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/SLA.0b013e3181571047","volume":"247","author":"WY Lau","year":"2008","unstructured":"Lau WY, Lai EC, Leung TW, Yu SC. Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival. Ann Surg 2008;247:43\u20138.","journal-title":"Ann Surg"},{"key":"1812_CR8","first-page":"70","volume":"35","author":"WT Leung","year":"1994","unstructured":"Leung WT, Lau WY, Ho SK, Chan M, Leung NW, Lin J, et al. Measuring lung shunting in hepatocellular carcinoma with intrahepatic-arterial technetium-99m macroaggregated albumin. J Nucl Med 1994;35:70\u20133.","journal-title":"J Nucl Med"},{"key":"1812_CR9","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1007\/s00259-010-1566-2","volume":"37","author":"B Lambert","year":"2010","unstructured":"Lambert B, Mertens J, Sturm EJ, Stienaers S, Defreyne L, D\u2019Asseler Y. 99mTc-labelled macroaggregated albumin (MAA) scintigraphy for planning treatment with 90Y microspheres. Eur J Nucl Med Mol Imaging 2010;37:2328\u201333.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1812_CR10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0883-2897(87)90047-X","volume":"14","author":"GJ Ehrhardt","year":"1987","unstructured":"Ehrhardt GJ, Day DE. Therapeutic use of Y-90 microspheres. Int J Radiat Appl Instrum Part B Nucl Med Biol 1987;14:233\u201342.","journal-title":"Int J Radiat Appl Instrum Part B Nucl Med Biol"},{"key":"1812_CR11","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0360-3016(97)00818-3","volume":"40","author":"WY Lau","year":"1998","unstructured":"Lau WY, Ho S, Leung TW, Chan M, Ho R, Johnson PJ, et al. Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres. Int J Radiat Oncol Biol Phys 1998;40:583\u201392.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1812_CR12","first-page":"1673","volume":"41","author":"JE Dancey","year":"2000","unstructured":"Dancey JE, Shepherd FA, Paul K, Sniderman KW, Houle S, Gabrys J, et al. Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres. J Nucl Med 2000;41:1673\u201381.","journal-title":"J Nucl Med"},{"key":"1812_CR13","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S1091-255X(01)80051-2","volume":"5","author":"RS Stubbs","year":"2001","unstructured":"Stubbs RS, Cannan RJ, Mitchell AW. Selective internal radiation therapy with 90yttrium microspheres for extensive colorectal liver metastases. J Gastrointest Surg 2001;5:294\u2013302.","journal-title":"J Gastrointest Surg"},{"key":"1812_CR14","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1053\/j.gastro.2004.09.034","volume":"127","author":"JFH Geschwind","year":"2004","unstructured":"Geschwind JFH, Salem R, Carr BI, Soulen MC, Thurston KG, Goin KA, et al. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. Gastroenterology 2004;127:S194\u2013205.","journal-title":"Gastroenterology"},{"key":"1812_CR15","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.ijrobp.2004.09.004","volume":"60","author":"AS Kennedy","year":"2004","unstructured":"Kennedy AS, Nutting DO, Coldwell D, Gaiser J, Drachenberg C. Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers. Int J Radiat Oncol Biol Phys 2004;60:1552\u201363.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1812_CR16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/01.RVI.0000142602.79459.90","volume":"16","author":"JE Goin","year":"2005","unstructured":"Goin JE, Salem R, Carr BI, Dancey JE, Soulen MC, Geschwind JFH, et al. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis. J Vasc Interv Radiol 2005;16:195\u2013203.","journal-title":"J Vasc Interv Radiol"},{"key":"1812_CR17","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1200\/JCO.2006.08.7916","volume":"25","author":"RA Sharma","year":"2007","unstructured":"Sharma RA, Van Hazel G, Morgan B, Berry D, Blanshard K, Price D, et al. Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. J Clin Oncol 2007;25:1099\u2013106.","journal-title":"J Clin Oncol"},{"key":"1812_CR18","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1023\/A:1013569329846","volume":"12","author":"B Gray","year":"2001","unstructured":"Gray B, Van Hazel G, Hope M, Burton M, Moroz P, Anderson J, et al. Randomised trial of SIR-Spheres\u00ae plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 2001;12:1711\u201320.","journal-title":"Ann Oncol"},{"key":"1812_CR19","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1002\/lt.20036","volume":"10","author":"BI Carr","year":"2004","unstructured":"Carr BI. Hepatic arterial 90yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients. Liver Transpl 2004;10:S107\u201310.","journal-title":"Liver Transpl"},{"key":"1812_CR20","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/jso.20141","volume":"88","author":"G Hazel Van","year":"2004","unstructured":"Van Hazel G, Blackwell A, Anderson J, Price D, Moroz P, Bower G, et al. Randomised phase 2 trial of SIR-Spheres plus fluorouracil\/leucovorin chemotherapy versus fluorouracil\/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol 2004;88:78\u201385.","journal-title":"J Surg Oncol"},{"key":"1812_CR21","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ijrobp.2006.05.065","volume":"66","author":"B Sangro","year":"2006","unstructured":"Sangro B, Bilbao J, Boan J, Martinez-Cuesta A, Benito A, Rodriguez J, et al. Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2006;66:792\u2013800.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1812_CR22","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00259-009-1279-6","volume":"37","author":"E Garin","year":"2010","unstructured":"Garin E, Rolland Y, Boucher E, Ardisson V, Laffont S, Boudjema K, et al. First experience of hepatic radioembolization using microspheres labelled with yttrium-90 (TheraSphere): practical aspects concerning its implementation. Eur J Nucl Med Mol Imaging 2010;37:453\u201361.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1812_CR23","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1118\/1.1781332","volume":"31","author":"M Sarfaraz","year":"2004","unstructured":"Sarfaraz M, Kennedy AS, Lodge MA, Li XA, Wu X, Yu CX. Radiation absorbed dose distribution in a patient treated with yttrium-90 microspheres for hepatocellular carcinoma. Med Phys 2004;31:2449\u201353.","journal-title":"Med Phys"},{"key":"1812_CR24","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s00259-002-0917-z","volume":"29","author":"K Bacher","year":"2002","unstructured":"Bacher K, Brans B, Monsieurs M, De Winter F, Dierckx RA, Thierens H. Thyroid uptake and radiation dose after (131)I-lipiodol treatment: is thyroid blocking by potassium iodide necessary? Eur J Nucl Med Mol Imaging 2002;29:1311\u20136.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1812_CR25","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0360-3016(02)02846-8","volume":"53","author":"LA Dawson","year":"2002","unstructured":"Dawson LA, Normolle D, Balter JM, McGinn CJ, Lawrence TS, Ten Haken RK. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 2002;53:810\u201321. Erratum in: Int J Radiat Oncol Biol Phys 2002;53:1422.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1812_CR26","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1088\/0031-9155\/53\/3\/014","volume":"53","author":"VA Semenenko","year":"2008","unstructured":"Semenenko VA, Li XA. Lyman-Kutcher-Burman NTCP model parameters for radiation pneumonitis and xerostomia based on combined analysis of published clinical data. Phys Med Biol 2008;53:737\u201355.","journal-title":"Phys Med Biol"},{"key":"1812_CR27","doi-asserted-by":"crossref","first-page":"S223","DOI":"10.1016\/S1051-0443(07)61790-4","volume":"13","author":"R Salem","year":"2002","unstructured":"Salem R, Thurston KG, Carr BI, Goin JE, Geschwind JF. Yttrium-90 microspheres: radiation therapy for unresectable liver cancer. J Vasc Interv Radiol 2002;13:S223\u20139.","journal-title":"J Vasc Interv Radiol"},{"key":"1812_CR28","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/01.RVI.0000233785.75257.9A","volume":"17","author":"R Salem","year":"2006","unstructured":"Salem R, Thurston KG. Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: technical and methodologic considerations. J Vasc Interv Radiol 2006;17:1251\u201378.","journal-title":"J Vasc Interv Radiol"},{"key":"1812_CR29","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1097\/01.RVI.0000235779.88652.53","volume":"17","author":"R Salem","year":"2006","unstructured":"Salem R, Thurston KG. Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics. J Vasc Interv Radiol 2006;17:1425\u201339.","journal-title":"J Vasc Interv Radiol"},{"key":"1812_CR30","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1097\/01.RVI.0000236744.34720.73","volume":"17","author":"R Salem","year":"2006","unstructured":"Salem R, Thurston KG. Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 3: comprehensive literature review and future direction. J Vasc Interv Radiol 2006;17:1571\u201394.","journal-title":"J Vasc Interv Radiol"},{"key":"1812_CR31","first-page":"1209","volume":"47","author":"SA Gulec","year":"2006","unstructured":"Gulec SA, Mesoloras G, Stabin M. Dosimetric techniques in 90Y-microsphere therapy of liver cancer: the MIRD equations for dose calculations. J Nucl Med 2006;47:1209\u201311.","journal-title":"J Nucl Med"},{"key":"1812_CR32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","volume":"21","author":"B Emami","year":"1991","unstructured":"Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21:109\u201322.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1812_CR33","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1007\/s00259-008-0857-3","volume":"35","author":"M Cremonesi","year":"2008","unstructured":"Cremonesi M, Ferrari M, Bartolomei M, Orsi F, Bonomo G, Aric\u00f2 D, et al. Radioembolisation with 90Y-microspheres: dosimetric and radiobiological investigation for multi-cycle treatment. Eur J Nucl Med Mol Imaging 2008;35:2088\u201396.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1812_CR34","first-page":"3024s","volume":"5","author":"ED Yorke","year":"1999","unstructured":"Yorke ED, Jackson A, Fox RA, Wessels BW, Gray BN. Can current models explain the lack of liver complications in Y-90 microsphere therapy? Clin Cancer Res 1999;5:3024s\u201330.","journal-title":"Clin Cancer Res"},{"key":"1812_CR35","first-page":"168","volume":"55","author":"C Chiesa","year":"2011","unstructured":"Chiesa C, Maccauro M, Romito R, Spreafico C, Pellizzari P, Negri A, et al. Need feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with 90Y microspheres: the experience on the National Cancer Institute of Milan. Q J Nucl Med Mol Imaging 2011;55:168\u201397.","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"1812_CR36","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.2967\/jnumed.110.075861","volume":"51","author":"L Strigari","year":"2010","unstructured":"Strigari L, Sciuto R, Rea S, Carpanese L, Pizzi G, Soriani A, et al. Efficacy and toxicity related to treatment of hepatocellular carcinoma with 90Y-SIR spheres: radiobiologic considerations. J Nucl Med 2010;51:1377\u201385.","journal-title":"J Nucl Med"},{"key":"1812_CR37","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1007\/s00259-009-1210-1","volume":"36","author":"R Lhommel","year":"2009","unstructured":"Lhommel R, Goffette P, Van den Eynde M, Jamar F, Pauwels S, Bilbao JI, et al. Yttrium-90 TOF PET scan demonstrates high-resolution biodistribution after liver SIRT. Eur J Nucl Med Mol Imaging 2009;36:1696.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1812_CR38","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1053\/j.semnuclmed.2007.10.006","volume":"38","author":"P Bernal","year":"2008","unstructured":"Bernal P, Raoul JL, Stare J, Sereegotov E, Sundram FX, Kumar A, et al. International Atomic Energy Agency-sponsored multination study of intra-arterial rhenium-188-labeled lipiodol in the treatment of inoperable hepatocellular carcinoma: results with special emphasis on prognostic value of dosimetric study. Semin Nucl Med 2008;38:S40\u20135.","journal-title":"Semin Nucl Med"},{"key":"1812_CR39","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00000658-199403000-00003","volume":"219","author":"DG Farmer","year":"1994","unstructured":"Farmer DG, Rosove MH, Shaked A, Busuttil RW. Current treatment modalities for hepatocellular carcinoma. Ann Surg 1994;219:236\u201347.","journal-title":"Ann Surg"},{"key":"1812_CR40","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/01.coc.0000236210.41199.91","volume":"29","author":"S Krishnan","year":"2006","unstructured":"Krishnan S, Lin EH, Gunn GB, Chandra A, Beddar AS, Briere TM, et al. Conformal radiotherapy of the dominant liver metastasis: a viable strategy for treatment of unresectable chemotherapy refractory colorectal cancer liver metastases. Am J Clin Oncol 2006;29:562\u20137.","journal-title":"Am J Clin Oncol"},{"key":"1812_CR41","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.1200\/JCO.2008.19.7996","volume":"26","author":"RK Kelley","year":"2008","unstructured":"Kelley RK, Venook AP. Sorafenib in hepatocellular carcinoma: separating the hype from the hope. J Clin Oncol 2008;26:5845\u20138.","journal-title":"J Clin Oncol"},{"key":"1812_CR42","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s00259-002-1108-7","volume":"30","author":"MA Monsieurs","year":"2003","unstructured":"Monsieurs MA, Bacher K, Brans B, Vral A, De Ridder L, Dierckx RA, et al. Patient dosimetry for 131I-lipiodol therapy. Eur J Nucl Med Mol Imaging 2003;30:554\u201361.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-011-1812-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-011-1812-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-011-1812-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T12:05:13Z","timestamp":1558699513000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-011-1812-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,15]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["1812"],"URL":"https:\/\/doi.org\/10.1007\/s00259-011-1812-2","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,15]]}}}